Katherine Winfree

6PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersQuery processing and optimisationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 30, 2023
Bayesian survival extrapolation for cost-effectiveness analysis: a case study of RELAY for ramucirumab in combination with erlotinib in the treatment of non-small-cell lung cancer.

Sory Traore, Andreas Sashegyi, Katherine B Winfree

|Feb 21, 2022
Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis.

Katrin Haeussler, Xuan Wang, Katherine B Winfree

|Sep 21, 2021
Study of patient characteristics, treatment patterns, EGFR testing patterns and outcomes in real-world patients with EGFRm+ non-small cell lung cancer.

Katherine B Winfree, Kristin M Sheffield, Zhanglin Lin Cui

|Apr 19, 2021
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations.

Katherine B Winfree, Cliff Molife, Patrick M Peterson

|Apr 12, 2021
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration.

Michael Grabner, Cliff Molife, Liya Wang

|Oct 13, 2017
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol.

Lisa M Hess, David M Kern, Gebra Cuyun Carter

Pageof 1

Frequent Collaborators

2 joint publications

Cliff Molife

2 joint publications

Liya Wang

2 joint publications

Zhanglin Lin Cui

2 joint publications

Gebra Cuyun Carter